Core Laboratories (CLB) Stock Price, News & Analysis

Company Overview

Core Laboratories N.V. (NYSE: CLB) is a leading provider of proprietary and patented technologies and services to the global upstream oil and gas industry. The company specializes in reservoir description, production enhancement and well site operations, offering a comprehensive suite of core analysis, formation evaluation, well testing and downhole monitoring solutions. By combining laboratory-based insight with field implementation, Core Labs helps clients optimize recovery, improve well performance and extend the productive life of mature assets.

Founded in 1936, Core Laboratories has grown into a truly international organization, serving exploration and production companies in more than 50 countries. Its corporate headquarters are in Amsterdam, with principal operating bases and laboratory facilities located in strategic petroleum provinces around the world. This global footprint enables Core Labs to support projects across North America, Latin America, Europe, the Middle East, Africa and Asia Pacific, tailoring services to local reservoir conditions and regulatory environments.

Core Laboratories maintains a strong focus on research and development, continually refining its diagnostic techniques and production technologies. Key offerings include advanced core and fluid analysis, pressure transient testing, geomechanics, reservoir simulation, enhanced oil recovery chemical formulations, and digital reservoir management tools. Through partnerships with industry, academia and research institutions, the company advances new applications in carbon capture, low-permeability resources and subsea evaluation, positioning itself at the forefront of energy transition solutions.

The company is led by Chief Executive Officer David P. Demshur, whose tenure has been marked by strategic investments in technology and geographic expansion. Under his leadership, Core Labs has emphasized operational excellence, client collaboration and sustainable practices, reinforcing its reputation for high‐value deliverables in challenging reservoir environments. The management team’s commitment to innovation and quality service has enabled Core Laboratories to maintain long-term partnerships with many of the world’s largest oil and gas producers.

Key Stats

• Today's Range: $12.37 to $12.97
• 50-Day Range: $10.62 to $12.91
• 52-Week Range: $10.14 to $25.13
• Volume: 61,541 shs
• Average Volume: 412,204 shs
• Market Capitalization: $601.70 million
• P/E Ratio: 21.75
• Dividend Yield: 0.31%
• Price Target: $15.00
• Consensus Rating: Reduce

Core Laboratories Stock Analysis - MarketRank™

Core Laboratories scored higher than 34% of companies evaluated by MarketBeat, and ranked 215th out of 266 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.9 / 5
• Analyst Rating: Reduce

Consensus Rating

Core Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.75, and is based on no buy ratings, 3 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Core Laboratories has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 15.63%

Earnings Growth

Earnings for Core Laboratories are expected to grow by 15.63% in the coming year, from $0.96 to $1.11 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Core Laboratories is 21.31, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.83.

Price to Earnings Ratio vs. Sector

The P/E ratio of Core Laboratories is 21.31, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 60.59.

Price to Earnings Growth Ratio

Core Laboratories has a PEG Ratio of 3.93. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Core Laboratories has a P/B Ratio of 2.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

16.95% of the float of Core Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Core Laboratories has a short interest ratio ("days to cover") of 15.3, which indicates bearish sentiment.

Change versus previous month

Short interest in Core Laboratories has recently increased by 4.24%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Core Laboratories has a dividend yield of 0.31%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Core Laboratories does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Core Laboratories is 6.78%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.60% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

16.95% of the float of Core Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Core Laboratories has a short interest ratio ("days to cover") of 15.3, which indicates bearish sentiment.

Change versus previous month

Short interest in Core Laboratories has recently increased by 4.24%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 3 news articles for Core Laboratories this week, compared to 3 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Core Laboratories insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.94% of the stock of Core Laboratories is held by insiders.

Percentage Held by Institutions

97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CLB Stock Analysis - Frequently Asked Questions

How have CLB shares performed this year?

Core Laboratories' stock was trading at $17.31 at the beginning of the year. Since then, CLB stock has decreased by 27.4% and is now trading at $12.57.

How were Core Laboratories' earnings last quarter?

Core Laboratories Inc. (NYSE:CLB) announced its quarterly earnings results on Wednesday, April, 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by $0.01. The company's revenue was down 4.7% compared to the same quarter last year.
Read the conference call transcript.

How do I buy shares of Core Laboratories?

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 4/23/2025
• Record date for 5/27 Dividend: 5/05/2025
• Ex-Dividend for 5/27 Dividend: 5/05/2025
• Dividend Payable: 5/27/2025
• Today: 7/10/2025
• Next Earnings (Estimated): 7/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Energy
• Industry: OIL - FIELD SVCS
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: NYSE:CLB
• CIK: 1000229
• Web: www.corelab.com
• Phone: (713) 328-2673
• Fax: N/A
• Employees: 3,500
• Year Founded: 1936

Price Target and Rating

• Average Price Target for Core Laboratories: $15.00
• High Price Target: $17.00
• Low Price Target: $13.00
• Potential Upside/Downside: +19.3%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.59
• Trailing P/E Ratio: 21.31
• Forward P/E Ratio: 13.09
• P/E Growth: 3.93
• Net Income: $31.40 million
• Net Margins: 5.41%
• Pretax Margin: 8.28%
• Return on Equity: 15.06%
• Return on Assets: 6.45%

Debt

• Debt-to-Equity Ratio: 0.48
• Current Ratio: 2.21
• Quick Ratio: 1.64

Sales & Book Value

• Annual Sales: $523.85 million
• Price / Sales: 1.12
• Cash Flow: $1.16 per share
• Price / Cash Flow: 10.83
• Book Value: $5.49 per share
• Price / Book: 2.29

Miscellaneous

• Outstanding Shares: 46,880,000
• Free Float: 46,442,000
• Market Cap: $589.28 million
• Optionable: Optionable
• Beta: 1.41